Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 30.
doi: 10.1055/a-2576-7760. Online ahead of print.

Personalized Medicine, Public Health and Patient-Centred Aspects in the Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation (PRESTIGE-AF) Project

Kirsten H Harvey  1 , Eleni Korompoki  1   2 , Emily R Harvey  1 , Cornelia Fießler  3 , Uwe Malzahn  3 , Klemens Hügen  3 , Sabine Ullmann  3 , Carolin Schuhmann  3 , Gabriele Putz Todd  3 , Joan Montaner  4   5 , Anna Penalba  5 , Daisy Guaman-Pilco  5 , Igor Sibon  6   7 , Stephanie Debette  8   9 , Timothy D'Aoust  8 , Morgane Lachaize  8   9 , Christian Enzinger  10 , Stefan Ropele  10 , Simon Fandler-Höfler  10 , Viktoria Ruecker  11 , Kirsten Haas  11 , Peter B Nielsen  12   13 , Charles Wolfe  14   15 , Yanzhong Wang  14 , Hatem Wafa  14 , Valeria Caso  16 , Maria Giulia Mosconi  16 , Gregory Y H Lip  13   17 , Deirdre A Lane  13   17   18 , Walter E Haefeli  19   20 , Kathrin I Foerster  20 , Viktoria S Wurmbach  19   20 , Peter Ringleb  21 , Peter U Heuschmann  3   11   22 , Roland Veltkamp  1   21   23 ; PRESTIGE-AF investigators
Affiliations
Free article

Personalized Medicine, Public Health and Patient-Centred Aspects in the Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation (PRESTIGE-AF) Project

Kirsten H Harvey et al. Thromb Haemost. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

All the authors received funding from European Union's Horizon 2020 research and innovation programme under grant agreement No. 754517 (PRESTIGE-AF). E.K. received Speaker Honoraria/Advisory boards/Travel grants from Amgen, AstraZeneca, Bayer, Elpen, Innovis, Pfizer, Sanofi. S.F.-H. received Honoraria/Travel grant from AstraZeneca. P.B.N. received Institutional support by grants of Daiichi Sankyo and Consultancy fees from Daiichi-Sankoy, Bayer; Speaker Honoraria/Advisory boards: SERVIER, Baye. Y.W. and H.W. received funding from The National Institute for Health and Care Research (NIHR) under its Program Grants for Applied Research (NIHR202339). V.C. received Consultancy from Bayer Steering Committee Oceanic AF; Speakers from Bayer, BMS-Pfizer alliance and Daiichi-Sankyo; serve as a leadership role from WSO Treasurer. D.A.L. received Institutional support for investigator-initiated quality improvement grants from Bristol-Myers Squibb and Pfizer; Speaker fees from Bayer, Boehringer Ingelheim, and Bristol-Myers Squibb/Pfizer; Consultancy fees from Bristol-Myers Squibb and Boehringer Ingelheim; all outside the submitted work. W.E.H. received institutional support by grants from Boehringer Ingelheim and Daiichi-Sankyo. P.R. received institution support by Boehringer Ingelheim, Bayer; Speaker fees from Boehringer Ingelheim, Bayer, Pfizer; Participation DSMB/Advisory board: CLOSURE-AF, NISCI. P.U.H. received institutional research grants by German Ministry of Research and Education, German Research Foundation, Federal Joint Committee (G-BA) within the Innovation fund, German Cancer Aid, German Heart Foundation, Bavarian State, Robert Koch Institute, University Hospital Heidelberg. R.V. received Speaker Honoraria/Advisory boards from AstraZeneca, Bayer, BMS-Pfizer alliance; Research support: Bayer, BMS-Pfizer alliance, Boehringer Ingelheim, Daiichi Sankyo, Medtronic, Biogen. All other authors declared no conflict of interest.

LinkOut - more resources